Exagen (XGN) EBT Margin Growth (5y) (2023 - 2026)
Exagen (XGN) EBT Margin Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Exagen | 156.59 Mn | 131.99 Mn | 12.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,416.00 |
| Mar 31, 2026 | 3,593.00 |
| Dec 31, 2025 | -107.00 |
| Sep 30, 2025 | -111.00 |
| Jun 30, 2025 | 1,199.00 |
| Mar 31, 2025 | 3,507.00 |
| Dec 31, 2024 | 567.00 |
| Sep 30, 2024 | -1,011.00 |
| Jun 30, 2024 | 690.00 |
| Mar 31, 2024 | 589.00 |
| Dec 31, 2023 | -4,674.00 |
| Sep 30, 2023 | -2,058.00 |